Clinical Trials Logo

Clinical Trial Summary

This study aims to better define the target range of ganciclovir trough concentrations by investigating the relationship between ganciclovir concentration and the time to undetectable CMV-DNA load, in preemptive and curative treatments by (val)ganciclovir.


Clinical Trial Description

The primary objective of the study is to determine whether higher concentrations of ganciclovir can reduce the time of negation of the CMV-DNA load. Secondary objectives are to determine the concentration-toxicity relationship of ganciclovir and the relationship between concentrations of ganciclovir and apparition of CMV gene mutations responsible of drug resistance. Each week, trough concentrations of ganciclovir are measured, associated with control of CMV-DNA load and all biological analysis currently necessary for the monitoring of the infection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03088553
Study type Observational
Source Rennes University Hospital
Contact Kristell COAT
Phone 2 99 28 91 91
Email kristell.coat@chu-rennes.fr
Status Recruiting
Phase
Start date February 21, 2017
Completion date June 21, 2024

See also
  Status Clinical Trial Phase
Completed NCT04328688 - Clindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.
Completed NCT00551837 - Immune Response to Influenza Vaccination N/A
Completed NCT01826721 - Impact of an E-learning Tool on Patient Satisfaction, Knowledge and Medication Adherence in Solid Organ Transplantation: A Randomized Controlled Trial N/A
Recruiting NCT01163578 - Biomarkers in Transplant Recipients to Improve Outcomes
Recruiting NCT05701228 - Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation
Not yet recruiting NCT05932030 - Assessment of Knowledge and Perceptions of Artificial Intelligence in Solid Organ Transplantation N/A
Completed NCT01178177 - Radiologic Features of Invasive Pulmonary Aspergillosis N/A